1. Home
  2. BCYC vs PGC Comparison

BCYC vs PGC Comparison

Compare BCYC & PGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • PGC
  • Stock Information
  • Founded
  • BCYC 2009
  • PGC 1921
  • Country
  • BCYC United Kingdom
  • PGC United States
  • Employees
  • BCYC N/A
  • PGC N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • PGC Commercial Banks
  • Sector
  • BCYC Health Care
  • PGC Finance
  • Exchange
  • BCYC Nasdaq
  • PGC Nasdaq
  • Market Cap
  • BCYC 581.7M
  • PGC 483.3M
  • IPO Year
  • BCYC 2019
  • PGC N/A
  • Fundamental
  • Price
  • BCYC $8.34
  • PGC $28.25
  • Analyst Decision
  • BCYC Buy
  • PGC Strong Buy
  • Analyst Count
  • BCYC 10
  • PGC 2
  • Target Price
  • BCYC $25.00
  • PGC $38.50
  • AVG Volume (30 Days)
  • BCYC 401.9K
  • PGC 90.2K
  • Earning Date
  • BCYC 05-01-2025
  • PGC 04-22-2025
  • Dividend Yield
  • BCYC N/A
  • PGC 0.70%
  • EPS Growth
  • BCYC N/A
  • PGC N/A
  • EPS
  • BCYC N/A
  • PGC 1.80
  • Revenue
  • BCYC $25,722,000.00
  • PGC $227,831,000.00
  • Revenue This Year
  • BCYC N/A
  • PGC $26.65
  • Revenue Next Year
  • BCYC $0.27
  • PGC $16.66
  • P/E Ratio
  • BCYC N/A
  • PGC $15.84
  • Revenue Growth
  • BCYC N/A
  • PGC 9.82
  • 52 Week Low
  • BCYC $6.10
  • PGC $20.30
  • 52 Week High
  • BCYC $28.67
  • PGC $37.88
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 49.88
  • PGC 54.08
  • Support Level
  • BCYC $7.95
  • PGC $27.90
  • Resistance Level
  • BCYC $9.55
  • PGC $28.86
  • Average True Range (ATR)
  • BCYC 0.72
  • PGC 0.87
  • MACD
  • BCYC 0.05
  • PGC 0.24
  • Stochastic Oscillator
  • BCYC 43.98
  • PGC 72.61

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About PGC Peapack-Gladstone Financial Corporation

Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.

Share on Social Networks: